FDA-Drug2014-01-29Class II

TEMAZEPAM, Capsule, 7.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378311001.

Aidapak Services, LLC
Hazard

Labeling: Label Mixup: TEMAZEPAM, Capsule, 7.5 mg may have potentially been mislabeled as one of the following drugs: CALCIUM CITRATE, Tablet, 200 mg Elemental Calcium, NDC 00904506260, Pedigree: AD28333_1, EXP: 5/8/2014; VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD49414_7, EXP: 5/17/2014.

Sold states
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Affected count
200 Capsules
Manufactured in
14301 Se 1st St, Vancouver, WA, United States
Products
TEMAZEPAM, Capsule, 7.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378311001.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-905-2014

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief